La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides

In English SILVER SPRING, Md., 24 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi (buprenorfina) de liberación prolongada para tratar el trastorno por consumo de opioides … Read more

Mirati Therapeutics Provides Update on the Phase 3 SAPPHIRE Study Evaluating Sitravatinib in Combination with OPDIVO®

SAN DIEGO, May 24, 2023 /PRNewswire/ — Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial-stage oncology company, today announced that the SAPPHIRE study did not meet its primary endpoint of overall survival at the final analysis. SAPPHIRE is a Phase 3 study evaluating sitravatinib in combination with nivolumab (OPDIVO®)1 versus docetaxel in patients with second or third … Read more

New AdventHealth Riverview Hospital Reaches Important Construction Milestone

“The topping out of AdventHealth Riverview Hospital is a significant milestone in our efforts to expand our reach and provide convenient access to quality healthcare throughout West Florida,” said David Ottati, President and CEO of the AdventHealth West Florida Division. “Our partnership with Robins & Morton and HuntonBrady has been invaluable in our expansion efforts … Read more

Increase in Fetal Chromosomal Abnormalities Drives Growth

DUBLIN, May 24, 2023 /PRNewswire/ — The “Carrier Screening Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global carrier screening market is expected to grow from $2.03 billion in 2022 to $2.38 billion in … Read more

Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023

MUMBAI, India, May 24, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31st March 2023. Consolidated Financial Highlights (In INR Crores) Particulars Quarterly Full Year Q4 FY23 Q4 FY22 YoYGrowth Q3 FY23 QoQGrowth FY23 FY22 YoYGrowth Revenue from … Read more

Gardiner Healthcare Acquisitions Corp. Announces Intent to Extend

SHAKER HEIGHTS, Ohio, May 24, 2023 /PRNewswire/ — Gardiner Healthcare Acquisitions Corp. (the “Company”) announced today that it intends to deposit into the Company’s trust account the amount of $100,000 in order to extend the period of time the Company has to consummate its initial business combination by an additional one month, from the current … Read more

New AICPA Chair Looks to Foster Innovation and Support the Next Generation of Accounting Professionals

Okorie L. Ramsey Elected as Chair of the American Institute of CPAs and the Association of International Certified Professional Accountants WASHINGTON, May 24, 2023 /PRNewswire/ — Okorie L. Ramsey, CPA, CGMA, PMP, NACD.DC, Vice President, Sarbanes/Oxley for Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals, is the new chair of the American Institute of CPAs … Read more

10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay

Combining tissue profiling with whole transcriptome spatial analysis and high-plex protein co-detection enables a deeper, more holistic understanding of tissue organization PLEASANTON, Calif., May 24, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAssist Gene and Protein Expression … Read more

Canary Speech Accelerates AI Speech Analysis Technology with Microsoft Cloud for Healthcare Integration

Digital vocal biomarker innovator integrates clinical-grade technology providing real-time speech analysis on Microsoft Cloud for Healthcare. PROVO, Utah, May 24, 2023 /PRNewswire/ — Canary Speech, Inc. announced today that it will apply the power of artificial intelligence (AI) voice analysis technology to address a variety of mental health challenges and enable early intervention, reduce healthcare … Read more

Penumbra, Inc. to Present at William Blair’s 43rd Annual Growth Stock Conference

ALAMEDA, Calif., May 24, 2023 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair’s 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023.   Event: William Blair’s 43rd Annual Growth Stock Conference Date:  Wednesday, June 7, 2023 Time:  9:20am CT/ 7:20am PT A webcast … Read more